Hot Stocks To Invest In 2019

Motley Fool co-founder David Gardner spends a lot of time focused on helping us all invest better, and his not-so-secret goal underneath that is to help us all live better. That’s why he began the Rule Breaker Investing podcast’s “Authors in August” theme with a couple of top-notch nonfiction writers: entrepreneur and marketing maven Seth Godin and gatherings guru Priya Parker. But sometimes, we all really need a book that transports us rather than teaches us.

So for this episode, David sits down with Amor Towle, author of one of his recent favorites, the enchanting A Gentleman in Moscow. It will be a wide-ranging discussion on the craft of writing, the art of story, the value of setting restrictions on where your creativity can take you, and more. Whether you’ve read Towle’s novel or not — if not, you may want to snag it for some late-summer beach reading — you should enjoy their talk.

A full transcript follows the video.

This video was recorded on Aug. 15, 2018.

Hot Stocks To Invest In 2019: Theravance Biopharma, Inc.(TBPH)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Theravance Biopharma (TBPH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Old West Investment Management LLC trimmed its position in Theravance Biopharma Inc (NASDAQ:TBPH) by 4.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 109,320 shares of the biopharmaceutical company’s stock after selling 4,542 shares during the period. Theravance Biopharma accounts for approximately 1.5% of Old West Investment Management LLC’s investment portfolio, making the stock its 25th biggest holding. Old West Investment Management LLC owned about 0.20% of Theravance Biopharma worth $2,651,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Theravance Biopharma Inc (NASDAQ:TBPH) has received an average recommendation of “Hold” from the nine research firms that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, two have given a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $41.33.

  • [By Motley Fool Transcribers]

    Theravance Biopharma Inc  (NASDAQ:TBPH)Q4 2018 Earnings Conference CallFeb. 26, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Chris Lange]

    Theravance Biopharma Inc. (NASDAQ: TBPH) is expected to report data from its Phase 2a study in patients with symptomatic neurogenic orthostatic hypotension by end of July 2018. Specifically, this data is in regards to its TD-9855 (norepinephrine serotonin reuptake inhibitor).

  • [By Ethan Ryder]

    Theravance Biopharma (NASDAQ: TBPH) and Synlogic (NASDAQ:SYBX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Hot Stocks To Invest In 2019: DNB Financial Corp(DNBF)

Advisors’ Opinion:

  • [By Shane Hupp]

    Southern First Bancshares (NASDAQ: DNBF) and DNB Financial Corp Common Stock (NASDAQ:DNBF) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership and dividends.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on DNB Financial Corp Common Stock (DNBF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    First Financial Bancorp (NASDAQ: DNBF) and DNB Financial Corp Common Stock (NASDAQ:DNBF) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on DNB Financial (DNBF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    DNB Financial Corp Common Stock (NASDAQ:DNBF) EVP Bruce E. Moroney sold 4,712 shares of the stock in a transaction that occurred on Wednesday, June 13th. The shares were sold at an average price of $35.93, for a total transaction of $169,302.16. Following the completion of the sale, the executive vice president now directly owns 16,502 shares of the company’s stock, valued at approximately $592,916.86. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Stephan Byrd]

    Media headlines about DNB Financial (NASDAQ:DNBF) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. DNB Financial earned a coverage optimism score of 0.01 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 47.919917781005 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Hot Stocks To Invest In 2019: Energy Fuels Inc(UUUU)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Energy Fuels (NYSEAMERICAN:UUUU) (TSE:EFR) shares saw an uptick in trading volume on Monday . 1,091,365 shares were traded during mid-day trading, an increase of 300% from the previous session’s volume of 272,846 shares.The stock last traded at $2.09 and had previously closed at $2.04.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Energy Fuels (UUUU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Energy Fuels (NYSEAMERICAN:UUUU) (TSE:EFR)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a note issued to investors on Wednesday. They presently have a $4.25 price objective on the basic materials company’s stock. HC Wainwright’s target price points to a potential upside of 58.58% from the company’s previous close.

  • [By Logan Wallace]

    Old West Investment Management LLC purchased a new stake in Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) in the first quarter, HoldingsChannel reports. The firm purchased 578,496 shares of the basic materials company’s stock, valued at approximately $1,003,000.

  • [By Stephan Byrd]

    Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 2,265,513 shares, an increase of 19.6% from the May 31st total of 1,893,582 shares. Based on an average daily volume of 589,166 shares, the days-to-cover ratio is presently 3.8 days. Approximately 3.3% of the shares of the stock are short sold.

Leave a Reply

Your email address will not be published. Required fields are marked *